Background-Left ventricular hypertrophy (LVH) is a common risk factor for cardiovascular mortality. Causes other than hypertension have not previously been investigated longitudinally. The aim of the present study was to determine hemodynamic, metabolic, and psychosocial predictors at 50 years of age for the prevalence of echocardiographic LVH and geometric subtypes at age 70 by use of a large sample of men from the general population followed up for 20 years. Methods and Results-In 1970 to 1973, all men born from 1920 to 1924 and residing in Uppsala County, Sweden, were invited to participate in a health survey aimed at identifying risk factors for cardiovascular disease. At a reinvestigation 20 years later, echocardiographic left ventricular mass index was determined in 475 subjects. A 1-SD increase in body mass index, systolic or diastolic blood pressure, fasting LDL/HDL cholesterol, serum triglycerides, or the serum cholesterol ester proportion of several saturated fatty acids or oleic acid at age 50 significantly increased the odds of having LVH at age 70 by 27% to 41%, whereas an increase in linoleic acid proportion was protective. Almost all metabolic predictors were independent of ischemic heart disease, valvular disease, and use of antihypertensive medication at age 70. Conclusions-Dyslipidemia and indices of a low dietary intake of linoleic acid and high intake of saturated and monounsaturated fats, as well as hypertension and obesity, at age 50 predicted the prevalence of LVH 20 years later in this prospective longitudinal cohort study, thereby suggesting that lipids may be important in the origin of LVH. (Circulation. 2001;103:836-841.)
trophy (LVH) is an important risk factor for cardiovascular and all-cause mortality and morbidity, 1, 2 and an increased left ventricular relative wall thickness (RWT; wall thickness divided by ventricular diameter) also has an adverse prognosis. 1, 3 The cause of LVH is largely unknown. Cross-sectional studies 4 -6 have shown male sex, age, hypertension, obesity, certain valvular diseases, and previous myocardial infarction to be related to LVH or left ventricular mass index (LVMI). Heredity 7 and alcohol use 8 might also explain some of the variance in left ventricular mass. In a prospective study, 9 average blood pressure over 30 years was associated with LVMI at follow-up. Hypertension is generally regarded as the worst culprit, as indicated by the large number of clinical trials on the subject. 10 However, the variation in 24-hour blood pressure explains only 25% to 30% of the variation in left ventricular mass. 11 Body size is a powerful determinant of left ventricular mass 12 and may explain part of the sex difference in left ventricular mass. 13 Weight reduction has been shown to decrease LVMI in overweight hypertensive patients even more than pharmacological antihypertensive treatment. 14 Associations have recently been found [15] [16] [17] between LVH and the insulin resistance syndrome. 18 The left ventricular geometric correlates of insulin resistance are not clear; some studies 16, 17, 19, 20 have found insulin resistance or impaired glucose tolerance to be more closely related to thick left ventricular walls or increased RWT than to LVH.
The fatty acid composition of serum cholesterol esters (CEs) mainly reflects dietary fat quality over the previous 2 weeks 21 and has been shown to predict myocardial infarction, 22 but its relationship to LVH is not known. Furthermore, the relationships between smoking or other psychosocial factors and later LVH are not known.
Thus, there is a need for prospective studies of modifiable predictors of LVH. The aim of the present study was to determine hemodynamic, metabolic, dietary, and psychosocial predictors at age 50 years for the prevalence of echocardiographic LVH and left ventricular geometric subtypes at age 70 years by use of a large, regionally determined sample of men from the general population followed up for 20 years.
Methods
In 1970 to 1973, all men born from 1920 to 1924 and residing in Uppsala County were invited to participate in a health survey 23 aimed at identifying risk factors for cardiovascular disease. Of the invited subjects, 2322 (82%) participated. At a reinvestigation of the cohort 20 years later, an echocardiographic examination was made in the first 583 consecutive subjects of 1221 available. The population of the present study consisted of 475 men in whom determination of left ventricular geometry was possible. 24 All subjects gave informed consent, and the study was approved by the Ethics Committee of Uppsala University. Procedures followed were in accordance with department guidelines.
Investigations at Age 50
These investigations have been described previously. 23 Blood pressure in the recumbent position was measured with a mercury manometer, and radial pulse rate was counted. All blood samples were drawn in the morning after an overnight fast. Blood glucose, serum insulin, cholesterol, triglycerides, and HDL cholesterol were measured, and LDL cholesterol was calculated with Friedewald's formula. The CE proportions of fatty acids (14:0 to 22:6 3) were determined by gas chromatography. 22 No dietary records were obtained, but in other population studies in middle-aged men in the 1970s in Sweden, intake of fat corresponded to Ϸ40%, of carbohydrates to 45% to 50%, and of protein to 13% to 15% of energy intake. The estimated intake of saturated fats corresponded to 17% to 18% of energy intake. At age 70, 7-day dietary records in 444 of the 475 subjects showed an intake of fat corresponding to 35%, of carbohydrates to 48%, and of protein to 16% of energy intake, which was comparable to other contemporary Swedish populations of the same age.
A questionnaire covered level of physical activity (4 categories) and education (5 categories). Coding of smoking (smoker, nonsmoker, ex-smoker), civil status, and socioeconomic status (3 social classes, Central Bureau of Statistics) was based on interview reports. 23
Investigations at Age 70
At age 70, 167 subjects were regularly using antihypertensive medication, and 38 used lipid-lowering drugs, of whom 16 used statins, 15 fibrates, 6 resins, and 2 nicotinic acid, as monotherapy or in combination. Fifty-four subjects had been hospitalized owing to ischemic heart disease (ICD-9 codes 410 to 414) between the investigations at 50 and 70 years of age. Seventeen subjects had significant echocardiographic valvular disease (aortic or mitral stenosis or regurgitation grades 3 or 4).
A comprehensive 2D and Doppler echocardiography examination was performed as described previously. 24 Left ventricular mass was divided by body surface area to obtain LVMI. LVH was defined as an LVMI Ն150 g/m 2 according to data from the Framingham Heart Study, 25 and a partition value of 0.44 26 was used for RWT [(interventricular septumϩposterior wall thickness)/left ventricular enddiastolic diameter]. Thus, left ventricular geometry was considered normal if RWT was Ͻ0.44 and LVMI was Ͻ150 g/m 2 . A normal LVMI with increased RWT was denoted concentric remodeling, 26 and a hypertrophic left ventricle was denoted eccentric if the RWT was normal and concentric if the RWT was increased.
Statistical Analysis
Variables with a skewed distribution (fasting serum insulin, triglycerides, LDL/HDL cholesterol, and CE proportion of palmitoleic, stearic, ␥-linolenic, ␣-linolenic, eicosapentaenoic, and docosahexaenoic acids) were logarithmically transformed to achieve normal distribution, and these transformed variables were used in all analyses. Logistic regression was used with LVH or increased RWT at age 70 as outcome variables and standardized continuous variables (meanϭ0, SDϭ1) or indicator variables for multilevel nominal variables at age 50 as explanatory variables. Multiple logistic regression was used to adjust for possible confounders, which were treated as dichotomous variables. Squared terms and interaction terms were tested in all regressions. ANOVA was used to calculate differences in means between left ventricular geometric subgroups and factorial ANOVA to adjust for possible confounders. Post hoc Bonferroni-adjusted comparisons were only performed if overall ANOVA was significant. A 2 test was used to evaluate differences in nominal variables between geometric subgroups. Two-tailed significance values were given with PϽ0.05 regarded as significant. Stata 6.0 software was used (Stata Corporation).
Results

Prediction of LVH
The prevalence of LVH at age 70 was 28% in the present cohort. Among the variables associated with the insulin resistance syndrome, a 1-SD increase in body mass index, systolic or diastolic blood pressure, fasting LDL/HDL cholesterol, or serum triglycerides at age 50 resulted in 27% to 41% increased odds of having LVH at age 70 (Table 1) . A 1-SD increase in the CE proportion of any of myristic (14:0), palmitic (16:0), stearic (18:0), oleic (18:1), or eicosapentaenoic acid (20:5 3) at age 50 increased the odds of having LVH at age 70 by 29% to 37%, whereas a 1-SD increase in the proportion of linoleic acid (18:2 6) at age 50 reduced the odds of having LVH at age 70 by 24% ( Table 1 ). Levels of physical activity, education, smoking, civil status, and socioeconomic status at age 50, crude or adjusted, were not associated with later LVH (data not shown). With simultaneous control for ischemic heart disease during follow-up, valvular disease, and use of antihypertensive medication at age 70, the adjusted odds ratios were similar to the crude odds ratios, but systolic and diastolic blood pressure and palmitic acid were no longer significantly associated with LVH (Table  1 ). With control also for body mass index at age 50, LDL/HDL cholesterol and proportions of stearic, oleic, linoleic, and eicosapentaenoic acids remained significant predictors of LVH.
Prediction of Increased Left Ventricular RWT
The prevalence of increased RWT at age 70 was 25% in the present cohort. A 1-SD increase in CE proportion of oleic acid (18:1), ␥-linolenic acid (18:3 6), or dihomo-␥-linolenic acid (20:3 6) at age 50 increased the odds of having increased RWT at age 70 by 28% to 32%, whereas a 1-SD increase in the proportion of linoleic acid (18:2 6) at age 50 reduced the odds of having increased RWT at age 70 by 26% ( Table 2 ). The studied psychosocial issues were not associated with increased RWT (data not shown). Controlling for ischemic heart disease during follow-up, valvular disease, and use of antihypertensive medication at age 70 gave results similar to the unadjusted analysis ( Table 2) . When body mass index at age 50 was also controlled for, proportions of oleic and linoleic acid remained significantly associated with increased RWT.
We reperformed all the above analyses in a subsample of 421 subjects without ischemic heart disease during follow-up. In logistic regression analysis with LVH at age 70 as the dependent variable, adjusted for valvular disease and use of antihypertensive medication at age 70, significant predictors were the same as when adjusted for ischemic heart disease during follow-up in the total sample, with the addition of total cholesterol and the exception of myristic acid (14:0). When increased RWT was used as dependent variable, only dihomo-␥-linolenic acid (20:3 6) was significant in the ischemic heart disease-free subsample.
In the total sample, when also adjusting for use of lipidlowering drugs at age 70 (adjusting for antihypertensive drugs, lipid-lowering drugs, and valvular disease at age 70 and ischemic heart disease during follow-up), the effect of triglycerides (Pϭ0.055) and LDL/HDL cholesterol (Pϭ0.063) on later LVH became of borderline significance, but body mass index and CE proportions of fatty acids 14:0, 18:0, 18:1, 18:2 6, and 20:5 3 remained significant, and the CE proportion of docosahexaenoic acid (22:6 3) became significantly directly related to later LVH. Regarding prediction of later increased RWT, the same adjustment made oleic acid lose significance, but other predictors remained significant.
Characteristics at Age 50 According to Left Ventricular Geometric Patterns at Age 70
The levels of several variables associated with the insulin resistance syndrome and CE proportions of several fatty acids determined at age 50 varied significantly between the 4 left ventricular geometry groups determined at age 70 (Table 3 ). In the concentric remodeling group, CE proportions of oleic (18:1) and ␥-linolenic acid (18:3 6) were significantly higher and the proportion of linoleic acid (18:2 6) was significantly lower than in the normal geometry group. In the concentric LVH group, diastolic blood pressure and CE proportions of myristic (14:0), palmitic (16:0), oleic (18:1), and eicosapentaenoic acid (20:5 3) were significantly higher and linoleic acid (18:2 6) was significantly lower than in the normal geometry group. In the eccentric LVH group, body mass index, systolic and diastolic blood pressure, fasting serum triglycerides, and CE proportions of oleic (18:1) and eicosapentaenoic acid (20:5 3) were significantly higher, and linoleic acid (18:2 6) was significantly lower than in the normal geometry group. The studied psychosocial factors did not vary between the left ventricular geometry groups (data not shown). With simultaneous control for ischemic heart disease during follow-up and for valvular disease and use of antihypertensive medication at age 70, differences between groups regarding proportions of oleic, linoleic, ␥-linolenic, and eicosapentaenoic acids were still significant, whereas other differences lost significance. When body mass index at 50 was also controlled for, differences in oleic, linoleic, and eicosapentaenoic acids remained significant.
Discussion
In this 20-year follow-up of a large, regionally determined sample of men from the general population, dyslipidemia and a CE fatty acid composition indicating a high dietary intake of saturated and monounsaturated fats and low intake of linoleic acid at age 50 predicted the prevalence of LVH at age 70 to a similar degree as hypertension and obesity. The impact of obesity, dyslipidemia, and an unfavorable fatty acid profile on LVH was independent of history of ischemic heart disease, valvular disease, and use of antihypertensive medication at age 70. The relationships between dyslipidemia and an unfavorable fatty acid profile and later LVH were also independent of obesity at age 50. Previously, hypertension has been related to the development of LVH in a prospective study, 9 but the predictive value of obesity, dyslipidemia, and indices of an unfavorable diet for LVH has never been shown. Focus has recently turned to the association between LVH and the insulin resistance syndrome. [15] [16] [17] 19, 20 Some crosssectional population studies on the subject exist, 15, 19, 20 but most studies have been made in small groups of hypertensive patients, which would not be ideal for the search for correlates to LVH other than hypertension. In the present study, lipid derangements, unfavorable fatty acid profile, and obesity seemed to be powerful longitudinal predictors of LVH development, in contrast to a cross-sectional analysis of the same cohort at age 70 in which several measures of glucose intolerance and insulin resistance were related to an increased RWT and concentric remodeling but less to LVH. 20 The reason for these differences is not clear, but the metabolic associations may be affected by the normally observed age-related increase in RWT. 27 The relationship between an unfavorable CE fatty acid composition and later LVH is important, because the fatty acid composition reflects dietary fat quality over the past couple of weeks 21 and thus is a modifiable risk factor. Previous studies of the present cohort have shown that a fatty acid profile indicating a high dietary intake of saturated fats and low intake of linoleic acid is related to insulin resistance 28 and predicts myocardial infarction over 19 years. 22 Because the impact of other traditional risk factors on myocardial infarction 22 was similar to their impact on LVH in the present study, LVH might be regarded as an intermediary risk factor on the pathway between the described risk factor profile and myocardial infarction. The apparently reciprocal effects of linoleic acid (which makes up Ͼ50% of all CE fatty acids) and the saturated fatty acids may be due to passive redistribution of the less abundant acids after changes in linoleic acid proportion occur but may also reflect true pathophysiological effects of the saturated fatty acids. In these men, the dietary source of oleic acid was not olive oil (which was not used by middle-aged men in Sweden in the early 1970s) but food groups containing a high proportion of saturated fatty acids, such as dairy products, solid margarines, and meat products. The low impact of 3 polyunsaturated fatty acids, which are generally regarded as favorable, and the initially surprising relationship between eicosapentaenoic acid (20:5 3) levels and later LVH may be because a high intake of linoleic acid-rich vegetable fats reduces 3-acid levels in serum 21 by a decreased conversion of ␣-linolenic acid (18:3 3) to eicosapentaenoic acid (20:5 3) through competition for the same enzyme systems. Other factors than dietary fat intake may affect CE fatty acid profile, but the relationships between LDL/HDL cholesterol and triglycerides and later LVH support the adverse role of a diet rich in saturated fats.
No psychosocial variables were associated with development of LVH in the present study, in accordance with a cross-sectional population study 15 in which exercise physical activity and smoking were not related to LVH. The present cohort has been closely monitored for 20 years and may therefore be healthier than average Swedish 70-year-old men. Thus, associations in the present study may be weaker than in the general population.
One limitation of the study is the lack of dietary records at baseline and the resulting lack of knowledge about any potential dietary certainties in the studied population, which might influence the generalizability of the findings of the present study. Other limitations of the study include absence of echocardiographic data at baseline, possible underestimation of the impact of variables with substantial measurement error or missing data, and bias due to loss to follow-up. Of course, confounding factors other than the ones for which we adjusted may also exist. Because many analyses were performed, some chance associations may have been found. This study has a limited generalizability to women and other age and ethnic groups, and further studies are needed for confirmation of these findings. In conclusion, dyslipidemia and indices of a low dietary intake of linoleic acid and high intake of saturated and monounsaturated fats, as well as obesity and hypertension, at age 50 predicted the prevalence of LVH at age 70 in this 20-year follow-up of a large, regionally determined sample of men derived from the general population. The impact of obesity, dyslipidemia, and evidence of high dietary intake of saturated fats on LVH was independent of history of ischemic heart disease, valvular disease, and use of antihypertensive medication, indicating that lipids may be important in the origin of LVH. Data are means or geometric means Ϯ SDs. Abbreviations as in Table 1 . *Adjusted for ischemic heart disease, valvular disease, and use of antihypertensive medication at age 70. †PϽ0.05; ‡PϽ0.01 for no difference from group with normal left ventricular geometry, crude analysis.
